How big is the China In Vitro Diagnostics Market?

The China In Vitro Diagnostics Market size is expected to reach USD 17.76 billion in 2024 and grow at a CAGR of 5.01% to reach USD 22.68 billion by 2029. Read More

What is the current China In Vitro Diagnostics Market size?

In 2024, the China In Vitro Diagnostics Market size is expected to reach USD 17.76 billion. Read More

Who are the key players in China In Vitro Diagnostics Market?

Autobio Diagnostics, Mindray Medical International Limited, Shanghai Kehua Bio-Engineering Co. Ltd., Maccura Biotechnology and Xiamen Boson Biotech are the major companies operating in the China In Vitro Diagnostics Market. Read More

What years does this China In Vitro Diagnostics Market cover, and what was the market size in 2023?

In 2023, the China In Vitro Diagnostics Market size was estimated at USD 16.87 billion. The report covers the China In Vitro Diagnostics Market historical market size for years: 2021, 2022 and 2023. The report also forecasts the China In Vitro Diagnostics Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

What are the key growth areas in the China IVD Market?

The key growth areas in the China IVD Market are a) Molecular diagnostics b) Immunoassays c) POCT (point-of-care testing) for rapid diagnoses Read More

What are the key growth drivers for the IVD market in China?

The key growth drivers for the IVD market in China are a) Rising healthcare spending b) Aging population c) Increasing focus on early disease detection Read More

China In Vitro Diagnostics Market Share

Statistics for the 2023 & 2024 China In Vitro Diagnostics market share, created by Mordor Intelligence™ Industry Reports. China In Vitro Diagnostics share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of China In Vitro Diagnostics Industry

The China IVD market is moderately competitive and consists of some major players. Many China diagnostics suppliers in this market are trying to expand their product portfolios to increase their global market share. These companies focus on strategies such as mergers and acquisitions, collaborations, and new product developments. Key China diagnostics manufacturers in the China in vitro diagnostics market are Abbott Laboratories, Shanghai Kehua Bio-Engineering Co., Ltd., Autobio Diagnostics Co., Mindray Medical International Limited, and Maccura Biotechnology, among others.